vx-993
Small moleculeexperimental
Clinical trial activity
9 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
7
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Dec 31, 2022 (NCT05653323)
Timeline
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06886269 | Phase 1 | Mar 21, 2025 | Vertex |
| NCT06619847 | Phase 2 | Oct 31, 2024 | Vertex |
| NCT06619860 | Phase 2 | Oct 18, 2024 | Vertex |
| NCT06523595 | Phase 1 | Jul 31, 2024 | Vertex |
| NCT06508762 | Phase 1 | Jul 26, 2024 | Vertex |
| NCT06394167 | Phase 1 | May 9, 2024 | Vertex |
| NCT06392659 | Phase 1 | May 2, 2024 | Vertex |
| NCT06226454 | Phase 1 | Jan 4, 2024 | Vertex |
| NCT05653323 | Phase 1 | Dec 31, 2022 | Vertex |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Vertex | For profit | 9 | 9 | 2 | 2022 |
1 organizations
Page 1 / 1